Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Using Biomarkers to Detect Cancer

Cancer Prevention: Lowering your Risk

Hypoxia Markers and Their Importance

Transforming Cancer Care through Genomic Testing

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

British Pioneers in Cancer Biology

Caring for a Loved One with Cancer

Targeted Cancer Therapies

Cancer Glossary

Cancer History

See more featured articles »

Pediatric Cancer

Cancer Pain Management

Is Cancer a Metabolic Disorder?

Secondary Brain Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

What is Tumorigenesis?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pain

Insight into Cancer Vaccines

Myc Mutations and Cancer

Overview of Cell Viability and Cytotoxicity

Cutaneous Manifestations of Internal Malignancy

What Role do Biobanks Play in Cancer Research?

Why are Cancer Cell Lines Useful?

What is the Tumor Microenvironment?

Cancer Classification

Microfluidic cancer treatment screen combined with flow cytometry

What Causes Cancer?

Living with Cancer Pain

Cancer Research

Metastatic Migration in Cancer may be Influenced by Metabolism

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

The Cancer Cell Surface Proteome as a Therapeutic Target

What is Cancer?

TARDIS: The Improved Method of Detecting Breast Cancer

What is Cancer of Unknown Primary?

Hot vs Cold: the differences between tumor types

Cancer Pathophysiology

Cancer Epidemiology

Cancer Diagnosis

Extracellular Vesicles as Floating Cancer Biomarkers

What is Merkel Cell Carcinoma?

Cancer Symptoms

Acidosis and Tumor Progression

Effects of Social and Economic Deprivation on Cancer Mortality

CDK9 and Cancer

The Effects of Cancer on Family Life

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Screening Considerations: Balancing the Benefits and Risks

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What is Immunochemotherapy?

Investigating the Molecular Mechanisms of Cancer

Insights into Oncofertility

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

The Biochemistry of Breast Cancer Screening

Secondary Lung Cancer

Cancer Management

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Prognosis

Latest Cancer News and Research

Experimental compound BA-101 overcomes chemotherapy resistance in glioblastoma

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive form of brain cancer: resistance to chemotherapy.

9 Jul 2026

Nine gut bacteria linked to future type 2 diabetes risk

Research identifies specific gut microbes associated with future type 2 diabetes risk, emphasizing the impact of dietary fiber on microbiome health.

9 Jul 2026

Researchers identify opioids with highest risk of respiratory depression

University of Manchester researchers have identified which opioids are most likely to be associated with respiratory depression, in a major new study.

9 Jul 2026

Study identifies new target for Parkinson's disease neuroprotection

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

8 Jul 2026

Setmelanotide shows promise for hypothalamic obesity after brain tumors

A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found.

8 Jul 2026

KU Ansan Hospital introduces the "Da Vinci 5" robotic system to boost surgical precision

The Robotic Surgery Center at Korea University Ansan Hospital has further strengthened its precision surgical capabilities with the introduction of the latest robotic surgical system, the "Da Vinci 5," marking the first deployment among tertiary hospitals in Gyeonggi Province.

8 Jul 2026

Toronto researchers uncover genetic drivers of triple negative breast cancer

Researchers have solved a long-standing mystery of how abnormal chromosomes drive cancer, identifying 81 new genes involved in aggressive breast cancer.

8 Jul 2026

Novel strategy can make stem cell transplants safer

Stem cell transplantation (also called bone marrow transplantation) and gene therapy are among the most powerful curative approaches for blood diseases such as sickle cell disease, b-thalassemia, immune deficiencies, and some blood cancers.

8 Jul 2026

Strategic collaboration funds interdisciplinary projects to improve cancer care

Rice University's Synthesis X Center and Houston Methodist Neal Cancer Center have awarded $90,000 in seed grants as part of a new strategic collaboration.

8 Jul 2026

NFL players have higher rates of neurodegenerative disease-caused mortality

Mass General Brigham, Boston University, and the Concussion & CTE Foundation cohort study of nearly 20,000 NFL players reveals that players are dying of dementia and Parkinson's disease at much higher rates than the general population.

8 Jul 2026

New study identifies shared risk factors for breast cancer and atrial fibrillation

Alcohol use and smoking were linked to breast cancer and atrial fibrillation/flutter in women ages 55 years and older in multiple regions of the world, according to new, independent research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

8 Jul 2026

Sexual and gender minority populations are less likely to receive cancer screening

A study reveals significant disparities in cancer screening rates among sexual and gender minorities, highlighting the need for equitable healthcare access.

8 Jul 2026

Yogurt, prebiotics, and probiotics link to lower colorectal cancer odds in U.S. adults

A national NHANES analysis of 9,405 U.S. adults aged 50 and older found that any yogurt, prebiotic, or probiotic consumption was associated with about 50% lower odds of self-reported colorectal cancer. Because the study was cross-sectional, it cannot prove causation but supports further research into microbiota-targeted dietary strategies.

8 Jul 2026

Hospital admissions for miscarriage and ectopic pregnancy rise in England

Hospital admissions for miscarriage and ectopic pregnancy have increased in England in recent years, according to research presented today at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).

7 Jul 2026

Emergency admissions associated with advanced ovarian cancer at diagnosis

Two in five women with ovarian cancer are diagnosed only after an emergency hospital admission, when they are 3 times less likely to have early stage and potentially curable disease, finds a data analysis published in the open access journal BMJ Oncology.

7 Jul 2026

Using manganese ferrite nanoparticles to better harness heat against cancer

Scientists have long known that heat can be used to help fight cancer. But heating up tumors and cancer cells is trickier than it sounds.

7 Jul 2026

Gut immune cells help prevent severe salmonella infections

Widely recognized as the face of food poisoning, salmonella bacteria lurk in raw meat and poultry, on pets and in unpasteurized dairy products.

7 Jul 2026

Study reveals why patients with rare leukemia develop resistance to tagraxofusp

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-approved treatment for this disease.

7 Jul 2026

Novel leukemia therapy successfully eradicates measurable residual disease

Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival outcomes, by treating with the antibody-drug conjugate (ADC) inotuzumab ozogamicin.

7 Jul 2026